Discontinuation of prophylactic medications for Cluster Headache, such as verapamil or lithium, requires gradual tapering to minimize potential rebound symptoms and physiological disruption. The medication's mechanism of action, typically involving calcium channel blockade or neurotransmitter modulation, means abrupt cessation can lead to destabilization of neurological and vascular regulatory mechanisms that were previously suppressed or controlled by the drug.